In all 2D and 3D cancer models with a strong (>40% positive tumor cells) Hsp90α/β protein expression, Pim qualified as a chemosensitizer potentiating the anti-tumor activity of standard-of-care chemotherapeutics. The gene discussed is PIM1; the disease is neoplasm.